A detailed history of Israel Englander (Millennium Management LLC) transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 23,100 shares of MEDP stock, worth $7.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,100
Previous 109,803 78.96%
Holding current value
$7.8 Million
Previous $45.2 Million 82.97%
% of portfolio
0.0%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$320.58 - $457.29 $1.05 Million - $1.5 Million
3,272 Added 2.98%
113,075 $37.7 Million
Q2 2024

Aug 14, 2024

SELL
$372.0 - $424.34 $9.53 Million - $10.9 Million
-25,629 Reduced 18.92%
109,803 $45.2 Million
Q1 2024

May 15, 2024

BUY
$284.87 - $413.31 $19 Million - $27.6 Million
66,736 Added 97.15%
135,432 $54.7 Million
Q4 2023

Feb 14, 2024

SELL
$227.52 - $312.68 $81.9 Million - $113 Million
-360,081 Reduced 83.98%
68,696 $21.1 Million
Q2 2023

Aug 14, 2023

BUY
$187.26 - $240.17 $3.98 Million - $5.1 Million
21,234 Added 5.21%
428,777 $103 Million
Q1 2023

May 15, 2023

SELL
$174.31 - $239.52 $7.56 Million - $10.4 Million
-43,395 Reduced 9.62%
407,543 $76.6 Million
Q4 2022

Feb 14, 2023

BUY
$153.06 - $226.57 $37.2 Million - $55.1 Million
243,001 Added 116.86%
450,938 $95.8 Million
Q3 2022

Nov 14, 2022

BUY
$145.13 - $182.49 $1.72 Million - $2.16 Million
11,850 Added 6.04%
207,937 $32.7 Million
Q2 2022

Aug 15, 2022

BUY
$130.2 - $168.03 $3.2 Million - $4.13 Million
24,566 Added 14.32%
196,087 $29.3 Million
Q1 2022

May 16, 2022

BUY
$138.87 - $214.31 $16.9 Million - $26.1 Million
121,787 Added 244.88%
171,521 $28.1 Million
Q4 2021

Feb 14, 2022

SELL
$182.74 - $227.9 $653,660 - $815,198
-3,577 Reduced 6.71%
49,734 $10.8 Million
Q3 2021

Nov 15, 2021

BUY
$170.18 - $198.21 $7.14 Million - $8.32 Million
41,979 Added 370.45%
53,311 $10.1 Million
Q2 2021

Aug 16, 2021

BUY
$158.62 - $194.3 $1.8 Million - $2.2 Million
11,332 New
11,332 $2 Million
Q1 2021

May 17, 2021

SELL
$132.02 - $168.26 $575,211 - $733,108
-4,357 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$109.38 - $149.19 $10.2 Million - $14 Million
-93,550 Reduced 95.55%
4,357 $606,000
Q3 2020

Nov 16, 2020

BUY
$92.95 - $130.61 $6.89 Million - $9.68 Million
74,082 Added 310.94%
97,907 $10.9 Million
Q2 2020

Aug 14, 2020

BUY
$68.08 - $95.68 $1.62 Million - $2.28 Million
23,825 New
23,825 $2.22 Million
Q1 2020

May 14, 2020

SELL
$61.71 - $101.95 $186,240 - $307,685
-3,018 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$70.08 - $84.64 $5.91 Million - $7.14 Million
-84,358 Reduced 96.55%
3,018 $254,000
Q3 2019

Nov 14, 2019

SELL
$62.38 - $85.89 $49.3 Million - $67.9 Million
-790,448 Reduced 90.05%
87,376 $7.34 Million
Q2 2019

Aug 14, 2019

BUY
$53.64 - $65.42 $45.3 Million - $55.3 Million
844,891 Added 2565.48%
877,824 $2.77 Million
Q1 2019

May 14, 2019

SELL
$49.38 - $70.58 $11.7 Million - $16.7 Million
-236,693 Reduced 87.79%
32,933 $1.94 Million
Q4 2018

Feb 14, 2019

SELL
$46.97 - $63.98 $5.12 Million - $6.98 Million
-109,063 Reduced 28.8%
269,626 $14.3 Million
Q3 2018

Nov 14, 2018

BUY
$43.25 - $63.74 $12.5 Million - $18.5 Million
290,038 Added 327.17%
378,689 $22.7 Million
Q2 2018

Aug 14, 2018

BUY
$34.03 - $45.46 $3.02 Million - $4.03 Million
88,651 New
88,651 $3.81 Million
Q1 2018

May 15, 2018

SELL
$32.03 - $39.05 $443,743 - $540,998
-13,854 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$32.46 - $38.31 $2.65 Million - $3.13 Million
-81,772 Reduced 85.51%
13,854 $502,000
Q3 2017

Nov 14, 2017

BUY
$27.43 - $33.11 $2.62 Million - $3.17 Million
95,626
95,626 $3.05 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.5B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.